Santa Clara, Calif.-based Affymetrix Inc. also recently launched a human genome microarray product, the GeneChip[R] Human Genome U133 set. (1) However, the two products differ in three key areas. One difference involves the strategy each company ado...
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has granted MWG Biotech AG a non-exclusive license to provide research products and services in RNA inte ...Inc